Food for human consumption: Dietary supplements containing ephedrine alkaloids Correction,

[Federal Register: March 25, 2003 (Volume 68, Number 57)]

[Proposed Rules]

[Page 14360]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr25mr03-28]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 111

[Docket No. 95N-0304]

RIN 0910-AC51

Dietary Supplements Containing Ephedrine Alkaloids; Reopening of the Comment Period; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule; correction.

SUMMARY: The Food and Drug Administration is correcting a proposed rule that appeared in the Federal Register of March 5, 2003 (68 FR 10417). The document reopened for 30 days the comment period for a proposed rule entitled ``Dietary Supplements Containing Ephedrine Alkaloids'' (June 4, 1997, 62 FR 30678). The former document was published with an inadvertent error. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy and Planning (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.

SUPPLEMENTARY INFORMATION: In FR Doc. 03-5072, appearing on page 10417 in the Federal Register of Wednesday, March 5, 2003, the following correction is made:

1. On page 10420, in the second column, reference 7 is corrected to read:

7. Shekelle, P., S. Morton, M. Maglione, et al., ``Ephedra and Ephedrine for Weight Loss and Athletic Performance Enhancement: Clinical Efficacy and Side Effects,'' Evidence Report/Technology Assessment No. 76 (Prepared by Southern California Evidence-based Practice Center, RAND, under Contract No. 290-97-0001, Task Order No. 9), Agency for Healthcare Research and Quality, February 2003, Publication No. 03-E022, Rockville, MD.

Dated: March 17, 2003. William K. Hubbard, Associate Commissioner for Policy and Planning.

[FR Doc. 03-6963 Filed 3-24-03; 8:45 am]

BILLING CODE 4160-01-S